Invention Grant
- Patent Title: Elimination of hepatitis B virus with antiviral agents
-
Application No.: US16082747Application Date: 2017-03-09
-
Publication No.: US10752584B2Publication Date: 2020-08-25
- Inventor: Raymond F. Schinazi , Sebastien Boucle , Franck Amblard , Ozkan Sari , Leda Bassit
- Applicant: EMORY UNIVERSITY
- Applicant Address: US GA Atlanta
- Assignee: Emory University
- Current Assignee: Emory University
- Current Assignee Address: US GA Atlanta
- Agency: Nexsen Pruet, LLC
- Agent David S. Bradin
- International Application: PCT/US2017/021551 WO 20170309
- International Announcement: WO2017/156255 WO 20170914
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; A61K31/454 ; A61K31/427 ; A61K31/192 ; A61P31/20 ; C07D207/34 ; C07D249/04 ; C07D401/12 ; C07D403/12 ; A61K45/06 ; C07D417/12 ; A61K31/40 ; A61K31/41 ; A61K31/4178 ; A61K31/4184 ; A61K31/4192 ; A61K31/496 ; A61K31/506 ; A61K31/5377 ; C07D207/36 ; C07D401/06 ; C07D403/06
Abstract:
The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
Public/Granted literature
- US20190241514A1 ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS Public/Granted day:2019-08-08
Information query
IPC分类:
